Project Grant K99GM151477

Award Date 5/1/24
Completion Date 4/30/26
Dollars Obligated $371K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Tennessee, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to investigate the role of endogenously formed zinc protoporphyrin (ZnPP) in intracerebral hemorrhage (ICH)-induced brain damage. The total award is $537,508 and will fund the project from December 1, 2024 to November 30, 2029. The key objectives are to determine the conditions that...
This federal Project Grant award, totaling $661,537.00, was provided by the National Institute on Aging under the Aging Research program (CFDA 93.866) to the University of Kansas Center for Research Inc. The project aims to develop analytical tools and techniques to study how zinc signaling and oxidative stress impact dopamine neurotransmission in neurodegeneration, with a focus on Alzheimer's and Parkinson's disease. Specifically, the grant will fund the creation of new tools to measure how...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $274,750 to Rutgers, The State University of New Jersey to conduct research on the role of the CNNM2 protein in regulating magnesium homeostasis and its impact on neuronal function and development. The key objectives of this 2-year research project are to: 1) Determine...
The National Institute of Mental Health (NIMH) awarded Georgetown University a Project Grant under the Mental Health Research Grants program (CFDA 93.242) to investigate how the chromatin remodeling protein CHD1 controls signaling pathways involved in synaptic homeostatic plasticity. The $1,111,187 award, effective July 15, 2024 through January 31, 2029, aims to elucidate the mechanisms by which variants in the human CHD2 gene, associated with autism spectrum disorder and other...
This $1,324,515 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate the molecular mechanisms by which zinc regulates mammalian sperm function and fertility. The key objectives are to: 1) establish how zinc impacts sperm at mating, 2) delineate the mechanisms of zinc depletion during sperm capacitation, and 3) define how zinc alters sperm...
This $2,354,604 Project Grant awarded by the National Institute of Mental Health (NIMH, CFDA 93.242 Mental Health Research Grants) aims to better understand the role of the ARC protein complex in cognitive deficits associated with psychotic disorders like schizophrenia. The primary awardee, The General Hospital Corporation (Massachusetts General Hospital), will conduct a multi-pronged research effort to: Derive a quantitative structure-activity relationship to optimize compounds that enhance ARC...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $196,460.00 to the University of Rochester to conduct research on the role of the Integrator-Z3 module in regulating neuronal differentiation. The award, with a period of performance from December 1, 2024 to June 30, 2027, will support three primary research...
This federal Project Grant award of $429,000 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to investigate how synaptic adhesion proteins guide myelination of specific axons. The two-year project, awarded to the University of Colorado-Denver, aims to develop new tools to visualize axon-myelin interactions and create loss-of-function mutations in oligodendrocytes to determine if variants in genes encoding the...
This $289,119 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund research to investigate the role of the TBX1 gene in the development of cognitive speed deficits associated with neurodevelopmental disorders. The research aims to: Measure cognitive speed in spontaneous alternation and attentional set-shifting tasks in mice with conditional TBX1 heterozygosity during the neonatal or postnatal periods....
This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to investigate the effects of early life deprivation and enrichment on hippocampal synaptic development and cognitive function in mice. The $715,999 grant awarded to Yale University aims to test the hypothesis that impoverished rearing conditions inhibit the expression of the TREM2 receptor on microglia, leading to abnormal synaptic...

MAINTENANCE OF BRAIN HOMEOSTASIS BY AN ANCIENT ZINC METALLOCHAPERONE - SUMMARY ZINC BINDING METALLOPROTEINS AND METALLOENZYMES CONSTITUTE 10% OF THE VERTEBRATE METALLOPROTEOME AND ARE ESSENTIAL FOR MANY CELLULAR PROCESSES. DUE TO THE CRITICAL IMPORTANCE OF ZINC TO VERTEBRATE PHYSIOLOGY, ZINC DEFICIENCY LEADS TO NUMEROUS PATHOLOGIES AND IS INVOLVED IN THE PATHOGENESIS OF MANY NEUROLOGICAL DISORDERS. IN FACT, ZINC IS ONE OF THE MOST PREVALENT METAL IONS IN THE BRAIN WHERE IT SERVES IMPORTANT ROLES IN NEUROGENESIS, NEURONAL MIGRATION, AND DIFFERENTIATION. ZINC DEFICIENCY CONSTITUTES A PERVASIVE PUBLIC HEALTH PROBLEM CONSIDERING THAT APPROXIMATELY HALF OF THE WORLD'S POPULATION SUFFERS FROM DIETARY ZINC DEFICIENCY, NOW THE FIFTH MOST IMPORTANT RISK FACTOR FOR MORTALITY IN DEVELOPING COUNTRIES. DESPITE THE KNOWN IMPORTANCE OF ZINC COFACTORS TO CELLULAR FUNCTION, THE MECHANISMS BY WHICH ZINC LEVELS REGULATE TISSUE HOMEOSTASIS REMAINS POORLY DEFINED. CELLULAR ZINC HOMEOSTASIS IS MODULATED BY A SPECIALIZED FAMILY OF ZINC TRAFFICKING PROTEINS CALLED METALLOCHAPERONES. IT IS SPECULATED THAT METALLOCHAPERONES FACILITATE THE HIERARCHICAL DELIVERY OF METALS TO THEIR CLIENT PROTEINS THEREBY REGULATING CELLULAR AND ORGANISMAL HOMEOSTASIS. WE HAVE IDENTIFIED THE FIRST VERTEBRATE ZINC METALLOCHAPERONE, WHICH WE RECENTLY NAMED ZINC REGULATED GTPASE METALLOPROTEIN ACTIVATOR 1 (ZNG1). WE DEMONSTRATED THAT VERTEBRATE ZNG1 BINDS TO AND TRANSFERS ZINC TO METALLOPROTEINS TO PROMOTE THEIR ENZYMATIC ACTIVITY. FURTHER, WE IDENTIFIED NUMEROUS CANDIDATE ZNG1 CLIENT ZINC METALLOPROTEINS IN ZEBRAFISH AND MICE THAT ARE ASSOCIATED WITH BRAIN FUNCTION, INCLUDING THE ZINC-FINGER TRANSCRIPTION FACTORS, ZFHX3 AND ZFHX4. COLLECTIVELY THESE FINDINGS SUGGEST THAT ZNG1 IS A REGULATOR OF BRAIN DEVELOPMENT AND FUNCTION VIA INTERACTIONS WITH SPECIFIC ZN-REQUIRING TRANSCRIPTION FACTORS, WHICH WILL BE TESTED BY EXPERIMENTS PROPOSED IN THIS APPLICATION. THIS WORK IS EXPECTED TO DETERMINE THE IMPACT OF ZNG1 MEDIATED ZINC TRANSFER ON TRANSCRIPTION FACTOR ACTIVITY IN THE BRAIN (AIM 1) WHILE DEFINING THE ZNG1-DEPENDENT ZFHX3 AND ZFHX4 SIGNALING PATHWAYS IMPORTANT FOR NEURONAL DEVELOPMENT, NEURONAL RESPONSE TO STRESS, AND BEHAVIOR (AIM 2). COMPLETION OF THESE AIMS HAS THE POTENTIAL TO IDENTIFY ZNG1 AS A FACTOR THAT MODULATES SIGNALING IN THE BRAIN IN A MANNER THAT IS DEPENDENT UPON ZINC BIOAVAILABILITY. THESE FINDINGS WILL SHED LIGHT ON THE IN VIVO ROLE OF THE FIRST DISCOVERED ZINC METALLOCHAPERONE AND WILL VERTICALLY ADVANCE OUR UNDERSTANDING OF ZINC HOMEOSTASIS AND CONTRIBUTIONS TO THE PROGRESSION OF HUMAN NEUROLOGICAL DISORDERS.

Posted 4/25/24, 12:00 AM